Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ)
CNY 19.72
(0.15%)
CNY 19.72
(0.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.21 Billion | 925.15 Million | 494.11 Million | 273.31 Million | 812.14 Million | 350.88 Million |
| Net Income | 1.03 Billion | 865.81 Million | 421.08 Million | -269.85 Million | 718.19 Million | 694.94 Million |
| Depreciation & Amortization | 222.6 Million | 158.27 Million | 149.38 Million | 118.49 Million | 93.02 Million | 74 Million |
| Deferred income taxes | 131.03 Million | 62.42 Million | -115.95 Million | -361.34 Million | -18.26 Million | -18.02 Million |
| Stock-based compensation | 3.81 Million | 7.78 Million | 4.54 Million | - | 790.5 Thousand | -5.95 Million |
| Change in working capital | -1.15 Million | -76.62 Million | -270.47 Million | -276.43 Million | 16.07 Million | -392.37 Million |
| Other non-cash items | 3.95 Million | -92.51 Million | 305.52 Million | 701.1 Million | 2.32 Million | -25.68 Million |
| Investing Cash Flow | 6.61 Million | -215.55 Million | -803.13 Million | -583.96 Million | -793.95 Million | -755.63 Million |
| Investments in PPE | -138.87 Million | -355.2 Million | -569.41 Million | -617.06 Million | -962.87 Million | -458.44 Million |
| Acquisitions | 9.61 Million | 20.75 Million | 80.69 Thousand | 37.33 Thousand | 378.89 | -115.03 Million |
| Investment purchases | -4.57 Billion | -5.69 Billion | -4.31 Billion | -5.96 Billion | -2 Billion | -2.85 Billion |
| Sales/Maturities of investments | 4.72 Billion | 5.83 Billion | 4.09 Billion | 5.99 Billion | 2.18 Billion | 2.65 Billion |
| Other Investing Activities | -520 Thousand | -20.5 Million | -9.49 Million | -1.17 Million | -11.59 Million | 10.5 Million |
| Financing Cash Flow | -130.49 Million | -73.85 Million | -78.83 Million | 1.35 Billion | -230.25 Million | -205.33 Million |
| Debt repayment | -1.99 Million | -2.59 Million | -2.13 Million | -7.7 Million | - | - |
| Dividends payments | -137.91 Million | -91.94 Million | -91.94 Million | -244.58 Million | -188.13 Million | -188.54 Million |
| Common Stock Repurchased | - | - | - | -345.6 Thousand | -40.51 Million | -16.78 Million |
| Common Stock Issuance | - | - | - | 1.6 Billion | - | - |
| Other Financing Activities | 7.42 Million | 20.69 Million | 15.24 Million | 3.33 Million | -1.83 Million | -16.78 Million |
| Accounts receivables | -5.81 Million | 16.12 Million | 151.98 Million | 96.34 Million | -16.5 Million | -264.64 Million |
| Accounts payables | -61.36 Million | -116.71 Million | -249.46 Million | -34.45 Million | 60.55 Million | -29.98 Million |
| Inventory | -65.01 Million | -38.46 Million | -57.03 Million | 23.01 Million | -9.7 Million | -79.71 Million |
| Other working capital | 3.81 Million | 62.42 Million | -115.95 Million | -361.34 Million | -18.26 Million | -312.65 Million |
| Cash at beginning of period | 3.57 Billion | 2.93 Billion | 3.32 Billion | 2.28 Billion | 2.49 Billion | 3.1 Billion |
| Cash at end of period | 4.66 Billion | 3.57 Billion | 2.93 Billion | 3.32 Billion | 2.28 Billion | 2.49 Billion |
| Capital Expenditure | -138.87 Million | -355.2 Million | -569.41 Million | -617.06 Million | -962.87 Million | -458.44 Million |
| Effect of forex changes on cash | -211.71 Thousand | 986.8 Thousand | -869.42 Thousand | -2.59 Million | 2.67 Million | 1.63 Million |
| Net cash flow / Change in cash | 1.09 Billion | 636.73 Million | -388.72 Million | 1.04 Billion | -209.38 Million | -608.45 Million |
| Free Cash Flow | 1.07 Billion | 569.94 Million | -75.3 Million | -343.75 Million | -150.73 Million | -107.56 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 281.49 Million | 318.69 Million | 373.52 Million | 219.4 Million | 1.03 Billion | 300.02 Million |
| Depreciation & Amortization | - | 58.1 Million | 58.1 Million | 58.15 Million | 222.6 Million | -107.84 Million |
| Deferred income taxes | - | - | - | - | 131.03 Million | 36.45 Million |
| Stock-based compensation | - | 2.58 Million | - | 3.81 Million | 3.81 Million | -3.51 Million |
| Change in working capital | - | -110.61 Million | - | -67.01 Million | -1.15 Million | 70.84 Million |
| Other non-cash items | 169.1 Million | 157.86 Million | 32.41 Million | 74.72 Million | 3.95 Million | 154.05 Million |
| Investing Cash Flow | -141.02 Million | -192.28 Million | -2 Billion | 1.95 Billion | 6.61 Million | -919 Million |
| Investments in PPE | -41.99 Million | -23.53 Million | -52.05 Million | -35.38 Million | -138.87 Million | -20.39 Million |
| Acquisitions | 86.22 Thousand | 245.46 Thousand | 16.68 Thousand | 132.63 Thousand | 9.61 Million | 24.34 Thousand |
| Investment purchases | -260 Million | -2.12 Billion | -1.95 Billion | - | -4.57 Billion | -1.47 Billion |
| Sales/Maturities of investments | 161.14 Million | 1.95 Billion | - | 1.99 Billion | 4.72 Billion | 574.06 Million |
| Other Investing Activities | -176.46 Thousand | 220 Thousand | -180 Thousand | -20 Thousand | -520 Thousand | 300 Thousand |
| Financing Cash Flow | 6.59 Million | -349.68 Million | -107.24 Thousand | -151.07 Thousand | -130.49 Million | 8.97 Million |
| Debt repayment | - | - | - | - | -1.99 Million | - |
| Dividends payments | - | -349.39 Million | - | - | -137.91 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 6.59 Million | 107.24 Thousand | -107.24 Thousand | -151.07 Thousand | 7.42 Million | 8.97 Million |
| Accounts receivables | - | -100.4 Million | - | -5.81 Million | -5.81 Million | 40.73 Million |
| Accounts payables | - | - | - | - | -61.36 Million | 3.51 Million |
| Inventory | - | -12.79 Million | - | -65.01 Million | -65.01 Million | 30.1 Million |
| Other working capital | - | 2.58 Million | - | 3.81 Million | 3.81 Million | -3.51 Million |
| Cash at beginning of period | 2.94 Billion | 3.11 Billion | 4.66 Billion | 2.49 Billion | 3.57 Billion | 2.95 Billion |
| Cash at end of period | 3.26 Billion | 2.99 Billion | 3.07 Billion | 4.66 Billion | 4.66 Billion | 2.49 Billion |
| Capital Expenditure | -41.99 Million | -23.53 Million | -52.05 Million | -35.38 Million | -138.87 Million | -20.39 Million |
| Effect of forex changes on cash | -442.65 Thousand | -52.44 Thousand | -251.15 Thousand | -219.2 Thousand | -211.71 Thousand | -232.59 Thousand |
| Net cash flow / Change in cash | 314.57 Million | -113.63 Million | -1.59 Billion | 2.17 Billion | 1.09 Billion | -460.25 Million |
| Free Cash Flow | 408.6 Million | 394.91 Million | 353.88 Million | 200.59 Million | 1.07 Billion | 429.61 Million |
NERD
1030
NNGPF
006800
GTE
AURIONPRO